• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾移植受者艰难梭菌感染的发生率、危险因素和结局。

Incidence, Risk Factors, and Outcomes of Clostridium difficile Infections in Kidney Transplant Recipients.

机构信息

Multi-Organ Transplant Program, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada.

Division of Infectious Diseases, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada.

出版信息

Transplantation. 2018 Sep;102(9):1576-1581. doi: 10.1097/TP.0000000000002199.

DOI:10.1097/TP.0000000000002199
PMID:29620613
Abstract

BACKGROUND

Kidney transplant recipients (KTR) may be at increased risk for Clostridium difficile infections (CDI) but risk factors and outcomes in this population have not been well studied.

METHODS

An observational cohort study was conducted to determine the incidence, risk factors, and outcomes of CDI in KTR. A total of 1816 KTR transplanted between 2000 and 2013 at the Toronto General Hospital were included. Sixty-eight patients developed CDI. Controls were selected at a 4:1 ratio using risk-set sampling, and risk factors were explored using conditional logistic regression models. The impact of CDI on graft outcomes was evaluated using Cox proportional hazards models.

RESULTS

The incidence rate of CDI was 0.64 cases/100 person-years. Independent predictors of CDI included antibiotic use (odds ratio [OR], 2.88; 95% confidence interval [CI], 1.35-6.15), increased duration of hospitalization posttransplant (OR, 1.04; 95% CI, 1.02-1.06]), receiving a deceased donor kidney (OR, 2.98; 95% CI, 1.47-6.05), and a history of biopsy-proven acute rejection (OR, 5.82; 95% CI, 2.22-15.26). In the Cox proportional hazards model, CDI was found to be an independent risk factor for the subsequent development of biopsy-proven acute rejection (hazard ratio, 2.18; 95% CI, 1.34-3.55).

CONCLUSIONS

Our results confirm that transplant-specific factors place KTR at a higher risk for CDI. Clostridium difficile infections may increase the risk of adverse outcomes, such as biopsy-proven acute rejection. These findings emphasize the importance of preventive strategies to reduce the morbidity associated with CDI in KTR.

摘要

背景

肾移植受者(KTR)可能面临更高的艰难梭菌感染(CDI)风险,但该人群的风险因素和结局尚未得到充分研究。

方法

进行了一项观察性队列研究,以确定 KTR 中 CDI 的发生率、风险因素和结局。共纳入了 2000 年至 2013 年在多伦多总医院接受移植的 1816 名 KTR。68 例患者发生 CDI。使用风险集抽样以 4:1 的比例选择对照,并使用条件逻辑回归模型探索风险因素。使用 Cox 比例风险模型评估 CDI 对移植物结局的影响。

结果

CDI 的发病率为 0.64 例/100 人年。CDI 的独立预测因素包括抗生素使用(比值比[OR],2.88;95%置信区间[CI],1.35-6.15)、移植后住院时间延长(OR,1.04;95% CI,1.02-1.06))、接受已故供体肾脏(OR,2.98;95% CI,1.47-6.05)和活检证实的急性排斥反应史(OR,5.82;95% CI,2.22-15.26)。在 Cox 比例风险模型中,CDI 是随后发生活检证实的急性排斥反应的独立危险因素(危险比,2.18;95% CI,1.34-3.55)。

结论

我们的结果证实,移植特异性因素使 KTR 面临更高的 CDI 风险。艰难梭菌感染可能会增加不良结局的风险,例如活检证实的急性排斥反应。这些发现强调了采取预防策略的重要性,以降低 KTR 与 CDI 相关的发病率。

相似文献

1
Incidence, Risk Factors, and Outcomes of Clostridium difficile Infections in Kidney Transplant Recipients.肾移植受者艰难梭菌感染的发生率、危险因素和结局。
Transplantation. 2018 Sep;102(9):1576-1581. doi: 10.1097/TP.0000000000002199.
2
The epidemiology of Clostridium difficile infection in a national kidney transplant center.一家全国性肾脏移植中心艰难梭菌感染的流行病学情况
Clin Transplant. 2017 Jun;31(6). doi: 10.1111/ctr.12962. Epub 2017 Apr 12.
3
Risk factors associated with Clostridium difficile infection in kidney transplant recipients.肾移植受者中与艰难梭菌感染相关的危险因素。
Transpl Infect Dis. 2018 Aug;20(4):e12918. doi: 10.1111/tid.12918. Epub 2018 Jun 13.
4
Epidemiology, risk factors, and outcomes of Clostridium difficile infection in kidney transplant recipients.肾移植受者艰难梭菌感染的流行病学、危险因素及结局
Transpl Infect Dis. 2013 Apr;15(2):134-41. doi: 10.1111/tid.12030. Epub 2012 Nov 23.
5
Epidemiology, risk factors, and outcome of Clostridium difficile infection in heart and heart-lung transplant recipients.心脏及心肺移植受者艰难梭菌感染的流行病学、危险因素及结局
Clin Transplant. 2017 Jun;31(6). doi: 10.1111/ctr.12968. Epub 2017 Apr 17.
6
Incidence and Outcomes Associated With Clostridioides difficile Infection in Solid Organ Transplant Recipients.实体器官移植受者中艰难梭菌感染的发生率和结局。
JAMA Netw Open. 2021 Dec 1;4(12):e2141089. doi: 10.1001/jamanetworkopen.2021.41089.
7
Clostridium difficile infection is associated with graft loss in solid organ transplant recipients.艰难梭菌感染与实体器官移植受者移植物丢失有关。
Am J Transplant. 2018 Jul;18(7):1745-1754. doi: 10.1111/ajt.14640. Epub 2018 Jan 25.
8
Burden of Clostridium difficile infection between 2010 and 2013: Trends and outcomes from an academic center in Eastern Europe.2010年至2013年间艰难梭菌感染的负担:来自东欧一个学术中心的趋势和结果。
World J Gastroenterol. 2015 Jun 7;21(21):6728-35. doi: 10.3748/wjg.v21.i21.6728.
9
Risk factors associated with Clostridium difficile infection after kidney and pancreas transplantation.肾胰腺移植后艰难梭菌感染的相关危险因素。
Transpl Infect Dis. 2013 Oct;15(5):502-9. doi: 10.1111/tid.12113. Epub 2013 Jul 25.
10
Epidemiology, Risk Factors, and Outcomes After Early Posttransplant Infection in Renal Transplant Recipients.肾移植受者移植后早期感染的流行病学、危险因素和转归。
Ann Pharmacother. 2019 Oct;53(10):1020-1025. doi: 10.1177/1060028019845003. Epub 2019 Apr 21.

引用本文的文献

1
Impact of early surgical complications on kidney transplant outcomes.早期手术并发症对肾移植结局的影响。
BMC Surg. 2024 May 27;24(1):165. doi: 10.1186/s12893-024-02463-7.
2
infection: history, epidemiology, risk factors, prevention, clinical manifestations, treatment, and future options.感染:历史、流行病学、风险因素、预防、临床表现、治疗和未来选择。
Clin Microbiol Rev. 2024 Jun 13;37(2):e0013523. doi: 10.1128/cmr.00135-23. Epub 2024 Feb 29.
3
Infection in Kidney Transplant Recipients.肾移植受者的感染
Pathogens. 2024 Feb 4;13(2):140. doi: 10.3390/pathogens13020140.
4
Renal cell carcinoma in kidney transplant recipients: incidence, trends, clinical management & outcomes.肾移植受者的肾细胞癌:发病率、趋势、临床管理和结局。
World J Urol. 2023 Sep;41(9):2389-2395. doi: 10.1007/s00345-023-04495-9. Epub 2023 Jul 14.
5
Clinical burden of recurrent infection in the medicare population: A real-world claims analysis.医疗保险人群中复发性感染的临床负担:一项真实世界索赔分析。
Antimicrob Steward Healthc Epidemiol. 2022 Apr 11;2(1):e60. doi: 10.1017/ash.2022.2. eCollection 2022.
6
Incidence and Outcomes Associated With Clostridioides difficile Infection in Solid Organ Transplant Recipients.实体器官移植受者中艰难梭菌感染的发生率和结局。
JAMA Netw Open. 2021 Dec 1;4(12):e2141089. doi: 10.1001/jamanetworkopen.2021.41089.
7
Acute abdomen in the immunocompromised patient: WSES, SIS-E, WSIS, AAST, and GAIS guidelines.免疫功能低下患者的急腹症:WSES、SIS-E、WSIS、AAST 和 GAIS 指南。
World J Emerg Surg. 2021 Aug 9;16(1):40. doi: 10.1186/s13017-021-00380-1.
8
Ureteral strictures post-kidney transplantation: Trends, impact on patient outcomes, and clinical management.肾移植术后输尿管狭窄:趋势、对患者预后的影响及临床管理
Can Urol Assoc J. 2021 Oct;15(10):E524-E530. doi: 10.5489/cuaj.7003.
9
Incidence Rates and Risk Factors of Infection in Solid Organ and Hematopoietic Stem Cell Transplant Recipients.实体器官和造血干细胞移植受者感染的发病率及危险因素
Open Forum Infect Dis. 2019 Feb 19;6(4):ofz086. doi: 10.1093/ofid/ofz086. eCollection 2019 Apr.